Citation: M. Shankaran et Ga. Gudelsky, EFFECT OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ON HIPPOCAMPAL DOPAMINE AND SEROTONIN, Pharmacology, biochemistry and behavior, 61(4), 1998, pp. 361-366
Citation: Ga. Gudelsky, EFFECT OF ASCORBATE AND CYSTEINE ON THE 3,4-METHYLENEDIOXYMETHAMPHETAMINE-INDUCED DEPLETION OF BRAIN-SEROTONIN, Journal of neural transmission, 103(12), 1996, pp. 1397-1404
Citation: Ga. Gudelsky et Jf. Nash, CARRIER-MEDIATED RELEASE OF SEROTONIN BY 3,4-METHYLENEDIOXYMETHAMPHETAMINE - IMPLICATIONS FOR SEROTONIN-DOPAMINE INTERACTIONS, Journal of neurochemistry, 66(1), 1996, pp. 243-249
Citation: Bk. Yamamoto et al., MODULATION OF METHYLENEDIOXYMETHAMPHETAMINE-INDUCED STRIATAL DOPAMINERELEASE BY THE INTERACTION BETWEEN SEROTONIN AND GAMMA-AMINOBUTYRIC-ACID IN THE SUBSTANTIA-NIGRA, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1063-1070
Citation: Ga. Gudelsky, EFFECTS OF SIGMA-RECEPTOR LIGANDS ON THE EXTRACELLULAR CONCENTRATION OF DOPAMINE IN THE STRIATUM AND PREFRONTAL CORTEX OF THE RAT, European journal of pharmacology, 286(3), 1995, pp. 223-228
Authors:
NASH JF
ROTH BL
BRODKIN JD
NICHOLS DE
GUDELSKY GA
Citation: Jf. Nash et al., EFFECT OF THE R(-) AND S(-CELLS EXPRESSING 5-HT2A OR 5-HT2C RECEPTORS() ISOMERS OF MDA AND MDMA ON PHOSPHOTIDYL INOSITOL TURNOVER IN CULTURED), Neuroscience letters, 177(1-2), 1994, pp. 111-115
Authors:
NICHOLS DE
FRESCAS S
MARONALEWICKA D
HUANG XM
ROTH BL
GUDELSKY GA
NASH JF
Citation: De. Nichols et al., IMETHOXY-4-(TRIFLUOROMETHYL)PHENYL)-2-AMINOPROPANE - A POTENT SEROTONIN 5-HT2A 2C AGONIST/, Journal of medicinal chemistry, 37(25), 1994, pp. 4346-4351
Citation: Ga. Gudelsky et al., POTENTIATION OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE-INDUCED DOPAMINE RELEASE AND SEROTONIN NEUROTOXICITY BY 5-HT2 RECEPTOR AGONISTS, European journal of pharmacology, 264(3), 1994, pp. 325-330